Genentech's Drug Avistan Increases Chance For Blood Clots.

Published on Wednesday 19 November 2008 - 12:16

Summary :
Genentech's latest drug, Avistan which is the first FDA aprroved'therapy designed to inhibit angiogenesis by which new blood vessels'develop in the human body and and carry vital nutrients to a...
Read more

Information source

Latest iReports

http://www.ireport.com/index.jspa?sortBy=latest...

Website description
Latest and greatest community news

Articles published on this website : 1 / 7 days - 17 / 30 days

endgame: Hamas must agree to 'durable' ceasefire Jobless Man auctions résumé on eBay in hopes Rest in Peace Eartha Kitt Woman Survives 66 Pound Tumor, House Foreclosure Last Christmas With Mosley

Other articles published on other websites on the same day

Purdue Mann Institute Reveals First Round Of Biomed Tech-Commercialization Awards http://www.biotechtransferweek.com/ University of Kansas Research Arm Sues US Government Over Cancer Drug Inventorship http://www.biotechtransferweek.com/ Dancing for a cause - a cure for breast cancer http://www.gulfbreezenews.com/ Randy Credico: American Injustice -- Anthony Williams and New York's Drug Laws http://www.huffingtonpost.com/ BOOK REVIEW: Cancer Supportive Care: Advances in Therapeutic Strategies http://content.nejm.org/ Teens overlooked in clinical trials http://www.fiercebiotech.com/ Quintuple Bottom Breaks http://www.istockanalyst.com/ Robotic Surgery Allows Cancer Patients To Have Kids http://www.wdsu.com/ Lilly Offers Free Health Guide, Available throughout State http://www.hispanicbusiness.com/ European patent office restores breast cancer gene patent http://news.sawf.org/